Next Generation News and Research

RSS

Thomson Reuters ranks UC San Diego Health System as one of nation's top 15 major teaching hospitals

UC San Diego Health System was recently listed as one the nation's top 15 major teaching hospitals by Thomson Reuters, a leading provider of information and solutions to improve the cost and quality of health care. The award recognizes hospitals that have achieved excellence in clinical outcomes, patient safety, patient satisfaction, financial performance, and operational efficiency. This is first time UC San Diego Health System has been recognized with this honor.

7 Apr 2010

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Sigma-Aldrich® announced today that it has signed an agreement with New Mexico Highlands University through its licensee, Highlands Stable Isotope Corp., to exclusively distribute a novel set of patented stable isotope labeled synthetic reagents.

7 Apr 2010

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

The global nursing shortage is due in part to a lack of faculty in nursing schools and to a phenomenon known as nurse migration, where nurses leave their country of origin to work elsewhere. In response, the International Council of Nurses and the Honor Society of Nursing, Sigma Theta Tau International, supported by The Elsevier Foundation, will conduct the Global Summit on Nurse Faculty Migration-a meeting of nurse experts who will examine the problem, and identify realistic and measurable solutions.

7 Apr 2010

New study shows utility of Chronix Biomedical's serum DNA tests in MS

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis. Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

6 Apr 2010

$DFine brings advance access system for treating vertebral compression fractures$

DFine brings advance access system for treating vertebral compression fractures

DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that it has launched a next generation access system for the RF Kyphoplasty procedure using the StabiliT® Vertebral Augmentation System.

6 Apr 2010

APHA survey: 85% Americans are taking steps towards healthier living

Eighty-five percent of Americans characterize their lifestyle as somewhat or very healthy, according to a survey released today by the American Public Health Association.

6 Apr 2010

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Ingen Technologies, Inc., a leading manufacturer of respiratory medical devices, recently announced today that the SMART Nasal Cannula is a featured new product at the upcoming MedTrade convention in Las Vegas from May 10 through May 13, 2010. The Las Vegas MedTrade convention is the largest home health care expo in the world. Ingen is an exhibitor and will be part of the New Product showcase at MedTrade. The SMART Nasal Cannula is the Next-Generation of cannulas that improve oxygen therapy and reduce expenditures.

5 Apr 2010

Warner Chilcott, sanofi-aventis amend Actonel global collaboration agreement

Warner Chilcott plc and sanofi-aventis announced today an amendment to the Actonel® global collaboration agreement with respect to the parties' arrangement in the United States and Puerto Rico. Under the terms of the amendment, Warner Chilcott will take full operational control over the promotion, marketing and R&D decisions for Actonel in the United States and Puerto Rico, and will assume responsibility for all associated costs relating to those activities.

5 Apr 2010

Johns Hopkins Kimmel Cancer Center reviews top cancer stories

Surgeon Jeremy Richmon, M.D., at Johns Hopkins is using robotic assistance to cut away tumors of the tongue and tonsils. Conventional surgery leaves disfiguring neck and jaw scars, but the robotic procedure leaves no scar except for inside the mouth, and he says, patients retain good function of speech and swallowing.

5 Apr 2010

Research may help develop new ways to diagnose and treat communication disorders

An international research consortium has identified more than 800 genes that appear to play a role in the male zebra finch's ability to learn elaborate songs from his father. The researchers also found evidence that song behavior engages complex gene regulatory networks within the brain of the songbird- networks that rely on parts of the genome once considered junk.

5 Apr 2010

Study could aid in developing new, effective treatments for prostate cancer

Van Andel Research Institute (VARI) scientists have determined how two proteins required for the initiation and development of prostate cancer interact at the molecular level, which could lead to improved treatments for the disease.

3 Apr 2010

Scientific American features Echo Therapeutics' non-invasive, wireless Symphony tCGM System

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, announced today that its Symphony™ tCGM System has been featured in a March 31, 2010 online magazine article in Scientific American entitled "This Really Won't Hurt a Bit: Wireless Sensor Promises Diabetics Noninvasive Blood Sugar Readings," by Larry Greenemeier.

3 Apr 2010

Genome of Australian zebra finch decoded

Nearly all animals make sounds instinctively, but baby songbirds learn to sing in virtually the same way human infants learn to speak: by imitating a parent.

2 Apr 2010

U.S. Court upholds validity of Eli Lilly's Gemzar compound patent

Eli Lilly and Company today announced that the U.S. District Court for the Southern District of Indiana has upheld the validity of the company's compound patent on Gemzar® (gemcitabine HCl for injection). This decision maintains Lilly's U.S. exclusivity for Gemzar through November 15, 2010.

2 Apr 2010

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Seeking a way to confirm that patients have taken their medication, University of Florida engineering researchers have added a tiny microchip and digestible antenna to a standard pill capsule. The prototype is intended to pave the way for mass-produced pills that, when ingested, automatically alert doctors, loved ones or scientists working with patients in clinical drug trials.

1 Apr 2010

Canadian Blood Services renews partnership with DDB Canada and OMD Canada

Canadian Blood Services has renewed its partnership with DDB Canada and OMD Canada; signing a new, three-year contract for strategic advertising and media management services. Both DDB and OMD will continue to help recruit and retain the next generation of blood donors in Canada, in addition to helping expand and diversify the OneMatch Stem Cell and Marrow Network.

1 Apr 2010

RXi Pharmaceuticals reports net loss of 28% for 2009

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported financial results for the fourth quarter and year ended December 31, 2009.

31 Mar 2010

Fairbanks Institute and BioServe to co-market next generation biorepository, INbank

The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, and BioServe, a global provider of biomaterial and genetic research services, today announced that they will co-market INbank™, a next generation biorepository that was recently launched by The Fairbanks Institute.

31 Mar 2010

FDA grants priority review status for Isotechnika Pharma's voclosporin

Isotechnika Pharma Inc. today announced that the New Drug Application (NDA) for the Company's next generation calcineurin inhibitor, voclosporin, has been accepted for priority review as filed by the U.S. Food and Drug Administration (FDA). The application was submitted by Isotechnika's partner, Lux Biosciences, Inc.

31 Mar 2010

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.

30 Mar 2010

Next Generation News and Research

Thomson Reuters ranks UC San Diego Health System as one of nation's top 15 major teaching hospitals

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Global Summit on Nurse Faculty Migration to identify solutions for shortage of nurse faculty

New study shows utility of Chronix Biomedical's serum DNA tests in MS

DFine brings advance access system for treating vertebral compression fractures

APHA survey: 85% Americans are taking steps towards healthier living

Ingen Technologies's SMART Nasal Cannula to be featured at upcoming Las Vegas MedTrade convention

Warner Chilcott, sanofi-aventis amend Actonel global collaboration agreement

Johns Hopkins Kimmel Cancer Center reviews top cancer stories

Research may help develop new ways to diagnose and treat communication disorders

Study could aid in developing new, effective treatments for prostate cancer

Scientific American features Echo Therapeutics' non-invasive, wireless Symphony tCGM System

Genome of Australian zebra finch decoded

U.S. Court upholds validity of Eli Lilly's Gemzar compound patent

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Canadian Blood Services renews partnership with DDB Canada and OMD Canada

RXi Pharmaceuticals reports net loss of 28% for 2009

Fairbanks Institute and BioServe to co-market next generation biorepository, INbank

FDA grants priority review status for Isotechnika Pharma's voclosporin

Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News